{
    "key": "2013-0613",
    "name": "Dose 3 PCV 13 to dose 4 interval 8 wks-4 days.  Series complete.",
    "cdcTestId": "2013-0613",
    "changedInVersion": "1.0",
    "dateAdded": "2013-01-01T00:00:00",
    "dateUpdated": "2020-05-29T07:40:52.071",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "133",
                "dateAdministered": "2020-01-22T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PFR",
                "vaccineName": "PREVNAR 13"
            },
            {
                "cvx": "133",
                "dateAdministered": "2020-05-22T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PFR",
                "vaccineName": "PREVNAR 13"
            },
            {
                "cvx": "133",
                "dateAdministered": "2020-06-22T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PFR",
                "vaccineName": "PREVNAR 13"
            },
            {
                "cvx": "133",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PFR",
                "vaccineName": "PREVNAR 13"
            }
        ],
        "seriesStatus": "Complete"
    },
    "evaluationTestType": "Interval: At Absolute Minimum",
    "forecast": {
        "earliestDate": "0001-01-01T00:00:00",
        "forecastNum": "-",
        "pastDueDate": "0001-01-01T00:00:00",
        "recommendedDate": "0001-01-01T00:00:00"
    },
    "forecastTestType": "Not recommended: series complete",
    "generalDescription": "This test case describes when dose #3 to dose #4 of the Pnuemococcal 13 vaccine is administered at an interval of 8 weeks -4 days that dose #4 is considered to be valid. The series is complete.",
    "patient": {
        "dob": "2019-07-22T00:00:00",
        "gender": "F",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "133",
                "dateAdministered": "2020-01-22T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PFR",
                "vaccineName": "PREVNAR 13"
            },
            {
                "cvx": "133",
                "dateAdministered": "2020-05-22T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PFR",
                "vaccineName": "PREVNAR 13"
            },
            {
                "cvx": "133",
                "dateAdministered": "2020-06-22T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PFR",
                "vaccineName": "PREVNAR 13"
            },
            {
                "cvx": "133",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PFR",
                "vaccineName": "PREVNAR 13"
            }
        ]
    },
    "reasonForChange": "",
    "testcaseName": "Dose 3 PCV 13 to dose 4 interval 8 wks-4 days.  Series complete.",
    "vaccineGroup": "PCV"
}